Survival results of 3,786 patients with stage I or II laryngeal squamous cell carcinoma: a propensity score-based study

Carregando...
Imagem de Miniatura
Citações na Scopus
4
Tipo de produção
article
Data de publicação
2022
Título da Revista
ISSN da Revista
Título do Volume
Editora
ASSOC BRASILEIRA OTORRINOLARINGOLOGIA & CIRURGIA CERVICOFACIAL
Autores
CARVALHO, Genival Barbosa de
KOHLER, Hugo Fontan
LIRA, Renan Bezerra
VARTANIAN, Jose Guilherme
Citação
BRAZILIAN JOURNAL OF OTORHINOLARYNGOLOGY, v.88, n.3, p.337-344, 2022
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Introduction Laryngeal squamous cell carcinoma is the second most prevalent malignancy among head and neck tumors, and the treatment of patients with stage I or II disease can be performed with surgery or radiation therapy. National population studies describing therapeutic results comparing these modalities are unusual, but they can be very important to direct treatment guidelines. Objective To evaluate the survival results of patients with laryngeal squamous cell carcinoma at clinical stages I or II, according to the main therapeutic modalities used. Methods Cross-sectional, population-based study using the database of Fundacao Oncocentro de Sao Paulo from January 2000 to March 2019. Inclusion criteria were patients with laryngeal squamous cell carcinoma in clinical stages cT1-2N0. To compensate for the non-random allocation of patients and the imbalance between confounding variables between groups, we used the propensity score methodology. Results A total of 3786 patients met the inclusion criteria. Regarding the cT stage, there were 2171 patients (57.3%) with cT1 tumors. Patients in the public health system had a longer time between diagnosis and treatment (p similar to <similar to 0.001). The analysis by propensity score showed that patients treated with surgery had a tendency towards better disease-specific survival (p similar to=similar to 0.012). Comparing radiotherapy alone versus its combination with radiochemotherapy, radiotherapy alone showed a tendency towards a better survival rate (p similar to <similar to 0.001). Conclusion Analysis by propensity score identified better results for disease-specific survival in patients with laryngeal squamous cell carcinoma at clinical stages I and II treated by surgery when compared to radiotherapy.
Palavras-chave
Laryngeal cancer, Surgery, Radiotherapy, Prognostic factors
Referências
  1. Ali MS, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00973
  2. Anglemyer A, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000034.pub2
  3. [Anonymous], SURVEILLANCE EPIDEMI
  4. [Anonymous], BANCO DADOS FUNDACAO
  5. Bertolin A, 2020, LARYNGOSCOPE, V130, P431, DOI 10.1002/lary.27959
  6. Buka SL, 2018, HDB LIFE COURSE HLTH, V21
  7. Carvalho AL, 2005, INT J CANCER, V114, P806, DOI 10.1002/ijc.20740
  8. Dey P, 2002, COCHRANE DB SYST REV, P2
  9. Ferlay J, 2019, INT J CANCER, V144, P1941, DOI 10.1002/ijc.31937
  10. Forastiere AA, 2003, NEW ENGL J MED, V349, P2091, DOI 10.1056/NEJMoa031317
  11. Agra IMG, 2012, HEAD NECK-J SCI SPEC, V34, P727, DOI 10.1002/hed.21739
  12. Guimaraes AV, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30218-x
  13. Harada A, 2015, JPN J CLIN ONCOL, V45, P248, DOI 10.1093/jjco/hyu203
  14. Jones DA, 2010, AM J CLIN ONCOL-CANC, V33, P587, DOI 10.1097/COC.0b013e3181beaab0
  15. Kompelli AR, 2019, OTOLARYNG HEAD NECK, V160, P651, DOI 10.1177/0194599818803330
  16. Locatello LG, 2019, LARYNGOSCOPE, V129, P2328, DOI 10.1002/lary.27702
  17. Mimica X, 2019, HEAD NECK-J SCI SPEC, V41, P3906, DOI 10.1002/hed.25925
  18. Ministerio da Saude. Instituto Nacional de Cancer Jose Alencar Gomes da Silva, 2020, EST 2020 INC CANC BR
  19. O'Hara J, 2013, J LARYNGOL OTOL, V127, P732, DOI 10.1017/S0022215113001400
  20. Pattanayak CW, 2011, REV ESP CARDIOL, V64, P897, DOI 10.1016/j.recesp.2011.06.008
  21. Pontes P, 2011, BRAZ J OTORHINOLAR, V77, P299, DOI 10.1590/S1808-86942011000300005
  22. Gomes SCS, 2009, REV PANAM SALUD PUBL, V25, P113, DOI 10.1590/S1020-49892009000200003
  23. Thomas L, 2012, CANCER TREAT REV, V38, P203, DOI 10.1016/j.ctrv.2011.05.010
  24. Warner L, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002027.pub2
  25. WOLF GT, 1991, NEW ENGL J MED, V324, P1685, DOI 10.1056/nejm199106133242402
  26. Yoo J, 2014, HEAD NECK-J SCI SPEC, V36, P1807, DOI 10.1002/hed.23504